Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.290
+0.010 (0.78%)
Aug 6, 2026, 10:45 AM EDT - Market open
Ocugen Market Cap
Ocugen has a market cap or net worth of $436.69 million as of August 6, 2026. Its market cap has increased by 56.44% in one year.
Market Cap
436.69M
Enterprise Value
421.24M
1-Year Change
56.44%
Ranking
Category
Stock Price
$1.29
ChartMarket Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $436.69M, an increase of 1,233.44%. That is a compound annual growth rate of 45.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 436.69M | 3.57% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SL Science Holding | 452.55M |
| Prelude Therapeutics | 450.27M |
| Scribe Therapeutics | 448.97M |
| Prothena Corporation | 444.48M |
| Cabaletta Bio | 441.88M |
| Benitec Biopharma | 435.96M |
| Larimar Therapeutics | 427.97M |
| vTv Therapeutics | 426.76M |